DHS Working Papers No. 125
Informe sobre poblaciones clave.
Key populations brief.
Краткое руководство
Rappart sur les populations clés.
Journal of Pulmonary & Respiratory Medicine 6: 326. doi:10.4172/2161-105X.1000326
PQDx 0144-043-00 WHO
PQDx Public Report
November/2016, version 4.0
AIDSFree Case study series
This publication is made possible by the generous support of the American people through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and the U.S. Agency for International Development (USAID) under the terms of Cooperative Agreement AID-OAA-A-14-00046....
The contents are the responsibility of AIDSFree and do not necessarily reflect the views of PEPFAR, USAID, or the U.S. Government.
more
This new edition and fully updated publication replaces the 2012 UCG and is being circulated free of charge to all public and private sector prescribers, pharmacists, and regulatory authorities in the country
On 3 October 2016, Category 4 Hurricane Matthew cut a path of destruction across the Republic of Haiti. Its devastating winds and heavy rainfall caused widespread damage in the southwest of the country. The most affected departments are Grande-Anse, Sud, Sud-Est and Nippes. The death toll in the cou...ntry is rising to at least 473 and cholera is spreading.
A Flash Appeal was launched on 10 October to provide immediate support to 750 000 affected people for the next three months. Within this framework, the Food and Agriculture Organization of the United Nations (FAO) requires USD 9 million to provide immediate crop, livestock and fisheries support to 300 000 hurricane-affected people.
more
The guidelines are aimed at clinical professionals directly involved with and responsible for the care of adults with HIV infection, and at community advocates responsible for promoting the best interests and care of HIV-positive adults. They should be read in conjunction with other published BHIVA ...guidelines.
The 2016 interim update to the 2015 BHIVA antiretroviral guidelines has been published online to include tenofovir-alafenamide/emtricitabine as a preferred NRTI backbone for first-line therapy. Changes were based on new data and the consensus opinion of the writing committee. All changes to the guideline are highlighted and include updates to the chronic kidney disease and bone disease sections of special populations and some small changes to managing virological failure.
The 2019 interim statement provides updated advice on treatment with two-drug regimens
more
Technical Report
AIDS Medicines and diagnostics service
September 2016
SADJ August 2016, Vol 71 no 7 p314 - p318
Clinical Review
Globalization and Health201612:63; DOI: 10.1186/s12992-016-0195-3
The END TB Strategy
Интеграция совместного оказания услуг в связи с ТБ и ВИЧ во всеобъемлющий пакет помощи для потребителей инъекционных наркотиков
Encuesta Nacional de Condiciones de Vida 2015 (ENCOVI)